Adi Livneh

Direttore/Membro del Consiglio presso New N.I. Medical (2011) Ltd.

64 anni

Consumer Non-Durables

Health Technology

Profilo

Adi Livneh is currently a Director at New N.I.
Medical (2011) Ltd.
In the past, Livneh worked as the Chief Executive Officer at Tefron Ltd.
from 2008 to 2009.

Posizioni attive di Adi Livneh

Società	Posizione	Inizio
New N.I. Medical (2011) Ltd. New N.I. Medical (2011) Ltd. Medical SpecialtiesHealth Technology New N.I. Medical (2011) Ltd. provides a non-invasive cardiac output monitoring system called nicas, which helps manage hypertension, dialysis, and heart failure. The private company is based in Raanana, Israel and was founded in 2011. The system is easy to use, cost-effective, and provides accurate assessment of cardiovascular, respiratory, and fluid status. The Israeli company's flagship solution, nicas, is based on advanced, proprietary patented technology and is designed to be the preferred solution for various challenges in cardiovascular disease management. The CEO is Eyal Karev.	Direttore/Membro del Consiglio	-

Tutte le posizioni attive di Adi Livneh

Precedenti posizioni note di Adi Livneh

Società	Posizione	Fine
TEFRON LTD.	Presidente	17/11/2009

Vedi nel dettaglio l'esperienza di Adi Livneh

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Adi Livneh

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
TEFRON LTD.	Consumer Non-Durables

Aziende private	1
New N.I. Medical (2011) Ltd. New N.I. Medical (2011) Ltd. Medical SpecialtiesHealth Technology New N.I. Medical (2011) Ltd. provides a non-invasive cardiac output monitoring system called nicas, which helps manage hypertension, dialysis, and heart failure. The private company is based in Raanana, Israel and was founded in 2011. The system is easy to use, cost-effective, and provides accurate assessment of cardiovascular, respiratory, and fluid status. The Israeli company's flagship solution, nicas, is based on advanced, proprietary patented technology and is designed to be the preferred solution for various challenges in cardiovascular disease management. The CEO is Eyal Karev.	Health Technology